Core C -Centralized Laboratory Support Core

核心C - 集中实验室支持核心

基本信息

项目摘要

Core C: Project Summary/Abstract: A major focus of the UCLA-CDU Center for AIDS Research (CFAR) is facilitation of multidisciplinary science to advance research in HIV prevention, treatment, and ART-free remission. The Centralized Laboratory Support Core functions to provide investigators with a one-stop center for consultation and access to laboratory assays, cutting-edge technologies, and expertise to support innovative, multidisciplinary research. Laboratory services include assays focused on virology, immunology, and `omics' technologies including microbiome. In addition, this Core provides novel access to valuable human blood and mucosal specimens. These services enable timely and cost-effective access to these assays and tissues, which would be otherwise unattainable for many CFAR investigators. The Core will also work to develop new assays and research tools in response to the scientific interests of its users. The Core will also offer CAP/CLIA-certified laboratory services to support advancement of clinical research. Finally, the Core will also provide important training and education services to keep the CFAR community up to date on the latest technologies and specifically support early stage investigators in the transition to independence. Specifically, we propose to: 1) Facilitate basic and translational HIV/AIDS research through comprehensive laboratory services to assess HIV- 1 infection and immune responses; 2) Provide expertise in the design, implementation, and analysis of studies examining HIV-1 and the microbiome, metabolome, or proteome; 3) Support clinical research on HIV prevention, treatment, and ART-free remission through CAP/CLIA-certified laboratory services; and 4) Support and stimulate translational HIV/AIDS research by providing mentoring, training, and education programs in relevant laboratory techniques.
核心C:项目摘要/摘要:UCLA-CDU艾滋病研究中心(CFAR)的一个主要研究重点是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Grace M Aldrovandi其他文献

Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: A cross-sectional study
孕妇和非孕妇宫颈阴道分泌物中的免疫调节因子:横断面研究
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Jan Walter;Linda Fraga;Melanie J Orin;William D Decker;Theresa Gipps;Alice Stek;Grace M Aldrovandi
  • 通讯作者:
    Grace M Aldrovandi

Grace M Aldrovandi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Grace M Aldrovandi', 18)}}的其他基金

Core C -Centralized Laboratory Support Core
核心C - 集中实验室支持核心
  • 批准号:
    10609765
  • 财政年份:
    2022
  • 资助金额:
    $ 18.85万
  • 项目类别:
Study of Tecovirimat for Human Monkeypox Virus (STOMP)
Tecovirimat 针对人猴痘病毒 (STOMP) 的研究
  • 批准号:
    10689623
  • 财政年份:
    2022
  • 资助金额:
    $ 18.85万
  • 项目类别:
A5401 COVID Supplement
A5401 新冠肺炎补充剂
  • 批准号:
    10203227
  • 财政年份:
    2020
  • 资助金额:
    $ 18.85万
  • 项目类别:
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
母乳低聚糖和肠道微生物组对暴露于 HIV 的未感染婴儿生长和发病的影响
  • 批准号:
    9920737
  • 财政年份:
    2019
  • 资助金额:
    $ 18.85万
  • 项目类别:
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
母乳低聚糖和肠道微生物组对暴露于 HIV 的未感染婴儿生长和发病的影响
  • 批准号:
    10610833
  • 财政年份:
    2019
  • 资助金额:
    $ 18.85万
  • 项目类别:
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
母乳低聚糖和肠道微生物组对暴露于 HIV 的未感染婴儿生长和发病的影响
  • 批准号:
    10382305
  • 财政年份:
    2019
  • 资助金额:
    $ 18.85万
  • 项目类别:
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents
成熟、传染性和创伤(麻省理工学院)导致青少年对艾滋病毒的易感性
  • 批准号:
    9245320
  • 财政年份:
    2017
  • 资助金额:
    $ 18.85万
  • 项目类别:
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center
国际孕产妇儿科青少年艾滋病临床试验(IMPAACT)实验室中心
  • 批准号:
    9317270
  • 财政年份:
    2016
  • 资助金额:
    $ 18.85万
  • 项目类别:
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center
国际孕产妇儿科青少年艾滋病临床试验(IMPAACT)实验室中心
  • 批准号:
    9188522
  • 财政年份:
    2016
  • 资助金额:
    $ 18.85万
  • 项目类别:
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network
国际孕产妇、青少年和儿科治疗临床试验网络
  • 批准号:
    9986166
  • 财政年份:
    2014
  • 资助金额:
    $ 18.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了